Found: 17
Select item for more details and to access through your institution.
Median Age at HPV Infection Among Women in the United States: A Model-Based Analysis Informed by Real-world Data.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab111
- By:
- Publication type:
- Article
Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 11, p. N.PAG, doi. 10.1093/ofid/ofy218
- By:
- Publication type:
- Article
Cost-Effectiveness of HIV Screening in STD Clinics, Emergency Departments, and Inpatient Units: A Model-Based Analysis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0019936
- By:
- Publication type:
- Article
Cost-Effectiveness of Newborn Circumcision in Reducing Lifetime HIV Risk among U.S. Males.
- Published in:
- PLoS ONE, 2010, v. 5, n. 1, p. 1, doi. 10.1371/journal.pone.0008723
- By:
- Publication type:
- Article
Correction: Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe.
- Published in:
- Archives of Gynecology & Obstetrics, 2024, v. 309, n. 6, p. 2833, doi. 10.1007/s00404-024-07504-3
- By:
- Publication type:
- Article
Burden of CIN2+ diagnoses and conizations in women aged 18-45 years-a retrospective secondary data analysis of German statutory health insurance claims data.
- Published in:
- 2022
- By:
- Publication type:
- journal article
HPV vaccination uptake and administration from 2006 to 2016 in a commercially insured population of the United States.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cost-effectiveness of ceftolozane/ tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States
- Published in:
- Antimicrobial Resistance & Infection Control, 2017, v. 6, p. 1, doi. 10.1186/s13756-017-0264-2
- By:
- Publication type:
- Article
Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 9, p. 1326, doi. 10.1093/cid/cix1021
- By:
- Publication type:
- Article
Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 3, p. 355, doi. 10.1093/cid/cix809
- By:
- Publication type:
- Article
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 7, p. 1218, doi. 10.1093/cid/cix523
- By:
- Publication type:
- Article
Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cost-Effectiveness of Pooled Nucleic Acid Amplification Testing for Acute HIV Infection after Third-Generation HIV Antibody Screening and Rapid Testing in the United States: A Comparison of Three Public Health Settings.
- Published in:
- PLoS Medicine, 2010, v. 7, n. 9, p. 1, doi. 10.1371/journal.pmed.1000342
- By:
- Publication type:
- Article
Estimating the Burden of 2009 Pandemic Influenza A (H1N1) in the United States (April 2009–April 2010).
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. suppl_1, p. S75, doi. 10.1093/cid/ciq012
- By:
- Publication type:
- Article
The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong.
- Published in:
- Cost Effectiveness & Resource Allocation, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12962-021-00328-x
- By:
- Publication type:
- Article